{
    "2019-02-19": [
        [
            {
                "time": "",
                "original_text": "财通证券：将昭衍新药评级调高为\"买入\"",
                "features": {
                    "keywords": [
                        "财通证券",
                        "昭衍新药",
                        "评级调高",
                        "买入"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}